Abstract
A case of mulleroblastoma, a malignant mixed Muller tumour, of the uterine body was observed in a 51-year-old patient. This is a rare but severe tumour. Clinically, there is a long latence period and early haematogenous metastases leading to failure of radiotherapy and surgical treatment. Recent data, particularly from immunohistochemistry studies, would suggest that the epithelial component plays a major role in pathogenesis. A therapeutic approach combining surgery, aggressive chemotherapy and radiotherapy allows improved prognosis.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Fluorouracil / administration & dosage
-
Humans
-
Hysterectomy
-
Immunohistochemistry
-
Middle Aged
-
Mixed Tumor, Mullerian / drug therapy*
-
Mixed Tumor, Mullerian / pathology
-
Prognosis
-
Uterine Neoplasms / drug therapy*
-
Uterine Neoplasms / pathology
-
Vinblastine / administration & dosage
Substances
-
Vinblastine
-
Doxorubicin
-
Cyclophosphamide
-
Fluorouracil